Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans.

Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N.

J Clin Endocrinol Metab. 2006 Oct;91(10):3873-7. Epub 2006 Aug 1.

PMID:
16882743
2.

Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans.

Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N.

J Endocrinol Invest. 2011 Sep;34(8):615-9. doi: 10.3275/7409. Epub 2010 Dec 15.

PMID:
21164278
3.

High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.

Seino Y, Hirose H, Saito I, Itoh H.

Metabolism. 2009 Mar;58(3):355-60. doi: 10.1016/j.metabol.2008.10.008.

PMID:
19217451
4.

Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects.

Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C, Sweeney G.

J Clin Endocrinol Metab. 2007 Nov;92(11):4313-8. Epub 2007 Aug 14.

PMID:
17698903
5.
6.

High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study.

Zhu N, Pankow JS, Ballantyne CM, Couper D, Hoogeveen RC, Pereira M, Duncan BB, Schmidt MI.

J Clin Endocrinol Metab. 2010 Nov;95(11):5097-104. doi: 10.1210/jc.2010-0716. Epub 2010 Aug 18.

7.

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.

Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T; Funagata study.

Diabetes Care. 2003 Jul;26(7):2015-20.

PMID:
12832305
8.

Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans.

Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N.

Diabetes Care. 2003 Oct;26(10):2754-7.

PMID:
14514575
9.

Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.

Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.

Metabolism. 2009 Oct;58(10):1470-6. doi: 10.1016/j.metabol.2009.04.042. Epub 2009 Jul 9.

PMID:
19592051
10.

Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.

Liu G, Ding M, Chiuve SE, Rimm EB, Franks PW, Meigs JB, Hu FB, Sun Q.

Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2259-2267. Epub 2016 Sep 8.

11.
12.

Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes.

Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ.

Diabet Med. 2007 Mar;24(3):245-52.

PMID:
17305786
13.

Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.

Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, Ohashi J, Shimizu I, Fujii Y, Tanimoto M, Makino H.

Clin Endocrinol (Oxf). 2008 Mar;68(3):442-9. Epub 2007 Oct 29.

PMID:
17970779
14.

Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.

Graessler J, Gruber M, Radke RB, Kopprasch S, Schwarz PE, Kamke W, Bornstein SR, Fischer S.

Gerontology. 2011;57(4):316-26. doi: 10.1159/000316575. Epub 2010 Jun 11.

PMID:
20551622
15.

Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans.

Kim SY, Sy V, Araki T, Babushkin N, Huang D, Tan D, Liao E, Liu G, Wan S, Poretsky L, Seto-Young D.

J Diabetes. 2014 Jul;6(4):360-8. doi: 10.1111/1753-0407.12114. Epub 2014 Feb 26.

17.

Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays.

Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS.

Diabetes Care. 2007 Feb;30(2):280-5.

PMID:
17259495
18.

Hemoglobin is associated with serum high molecular weight adiponectin in Japanese community-dwelling persons.

Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M.

J Atheroscler Thromb. 2011;18(3):182-9. Epub 2010 Dec 10.

19.

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.

Aso Y, Suganuma R, Wakabayashi S, Hara K, Nakano T, Suetsugu M, Matsumoto S, Nakamachi T, Takebayashi K, Morita K, Inukai T.

Transl Res. 2009 Oct;154(4):175-82. doi: 10.1016/j.trsl.2009.07.005. Epub 2009 Aug 3.

PMID:
19766961
20.

Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study.

Roos M, Baumann M, Liu D, Heinemann FM, Lindemann M, Horn PA, Türk T, Lutz J, Heemann U, Witzke O, von Eynatten M.

Regul Pept. 2012 Oct 10;178(1-3):11-5. doi: 10.1016/j.regpep.2012.06.001. Epub 2012 Jun 27.

PMID:
22750635

Supplemental Content

Support Center